It has been shown that the more severe SJS and TEN occur mainly in HLA-B*15:02+ patients, whereas MPE and DRESS following CBZ-treatment more likely arise in HLA-A*31:01+ patients [11,20]. This evidence concerns the gene HLA-A and toxic epidermal necrolysis.